In a nonalcoholic steatohepatitis (NASH)-HCC mouse model, FGF15/FGFR4 signaling plays a critical role in HCC initiation and development via stimulating EMT and Wnt/β-catenin signaling (Cui et al., 2018). Here, FGFR4 is linked to metabolic dysfunction-associated steatohepatitis.